Try our Investor Tool
Login
Sign Up

Login
Sign Up

Features
Pricing
Reg.News
Contact

Try our Investor Tool
Login
Sign Up

Search

Providers
Companies

⨯

LIVE

Event in Progress:

Join Here ×

Search

Providers
Companies

⨯

Features
Pricing
Event Hub
Transactions
Reg.News
Short Interest
Contact

Research >: Rude Health - finnCap Life Sciences quarterly sector note

28 Apr 2021

Rude Health - finnCap Life Sciences quarterly sector note

Bioventix Plc (BVXP:LON), 3,875 | Byotrol plc (BYOT:LON), 0.5 | Cambridge Nutritional Sciences PLC (CNSL:LON), 2.6 | SDI Group plc (SDI:LON), 108 | Synairgen plc (SNG:LON), 7.8 | Tristel Plc (TSTL:LON), 458 | Shield Therapeutics Plc (STX:LON), 6.1 | Destiny Pharma Plc (DEST:LON), 72.0 | Evgen Pharma Plc (EVG:LON), 1.7 | Genedrive Plc (GDR:LON), 11.4 | hVIVO plc (HVO:LON), 19.8 | 4basebio PLC (4BB:LON), 590

- Mark Brewer | Cavendish Research
- 38 pages

Summary: In this report we outline the investment case for three companies that we believe are primed for growth: Diurnal, Kromek and Oxford Biodynamics. We also include the outlook for the AIM healthcare sector and overall healthcare sector, industry and capital market indicators, key sector news, recent research highlights and a profile of all the companies covered by the finnCap Life Sciences team.

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers

Already a member? Log in here

Rude Health - finnCap Life Sciences quarterly sector note

Bioventix Plc (BVXP:LON), 3,875 | Byotrol plc (BYOT:LON), 0.5 | Cambridge Nutritional Sciences PLC (CNSL:LON), 2.6 | SDI Group plc (SDI:LON), 108 | Synairgen plc (SNG:LON), 7.8 | Tristel Plc (TSTL:LON), 458 | Shield Therapeutics Plc (STX:LON), 6.1 | Destiny Pharma Plc (DEST:LON), 72.0 | Evgen Pharma Plc (EVG:LON), 1.7 | Genedrive Plc (GDR:LON), 11.4 | hVIVO plc (HVO:LON), 19.8 | 4basebio PLC (4BB:LON), 590

Published: 28 Apr 2021
Author: Mark Brewer | Cavendish Research
Pages: 38

Summary: In this report we outline the investment case for three companies that we believe are primed for growth: Diurnal, Kromek and Oxford Biodynamics. We also include the outlook for the AIM healthcare sector and overall healthcare sector, industry and capital market indicators, key sector news, recent research highlights and a profile of all the companies covered by the finnCap Life Sciences team.

More Content

More Content

Hybridan Small Cap Feast 30 Nov 23

Companies: ZOO WYN SBTX PRM POLB GBP GDR GDR DXSP AAU

4basebio - Interims – scaling to meet anticipated commercial traction

Companies: 4basebio PLC

Cambridge Nutritional Sciences - H1 2024 interims: Executing a newly focussed st

Companies: Cambridge Nutritional Sciences PLC

PROGRESSIVE: SDI Group: Acquisition of Peak Sensors

Companies: SDI Group plc

Morning Note – 27 November 2023

Companies: CNSL HEIQ JOG

Useful Links

Features
Pricing
RNS/Newswires Feeds
Providers Hub
Company Hub

Account

Login
Free Trial - Join Now
Contact

Follow us on Linkedin Follow us on Twitter

Share:

Copyright © 2023 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top

Home
Features
Pricing
Event Hub
Transactions
Reg.News
Short Interest Tracker
Blogs
Ideas & Picks
- Ideas Hub
- Stock Pick League
Explore Content
Providers
Contact
Sign Up
Sign In